Moreover, cardiolipin, which functions upstream of NLRP3 inflammasome activation, has been shown to favor NLRP3 activation and the progression of NASH [14], further supporting the role of NLRP3 inflammasome in NASH [15]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.